Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Merck & Co Inc MRK

Healthcare
Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for... see more

Recent & Breaking News (NYSE:MRK)

Technical Review: New Releases from Drug Maker Majors Cushion Against Patent Cliff Effects

PR Newswire January 16, 2013

Merck Provides Update on Next Steps for TREDAPTIVE(tm) (extended-release niacin/laropiprant)

Business Wire January 11, 2013

Merck to Present at the 31st Annual J.P. Morgan Healthcare Conference

Business Wire January 4, 2013

The Real Story Behind GE, UN, MRK and JNJ

Marketwired January 4, 2013

Merck Announces FDA Acknowledgement of Resubmission of New Drug Application for Ezetimibe/Atorvastatin Tablets

Business Wire January 2, 2013

Merck to Present at 2013 Goldman Sachs Healthcare CEOs Unscripted: A View from the Top

Business Wire January 2, 2013

Merck Announces Fourth-Quarter 2012 Sales and Earnings Conference Call

Business Wire January 2, 2013

Perfect Trade Setups, How to Play AEZS, RAD, MRK and NXY

Marketwired December 31, 2012

Friday's Most Active - AAPL, DELL, MRK and JNJ

Marketwired December 28, 2012

The Real Story Behind MRK, NLY, PBR and HMA

Marketwired December 21, 2012

Merck Announces HPS2-THRIVE Study of TREDAPTIVE(tm) (Extended-Release Niacin/Laropiprant) Did Not Achieve Primary Endpoint

Business Wire December 20, 2012

Penny stocks more trustworthy than Somali pirate exchange

John Whitefoot December 7, 2009

Cardiome shares surge on Merck agreement

Buzz on the Boards April 9, 2009

Equity, commodity trading highlight importance of confidence

Colin Cieszynski March 9, 2009